Literature DB >> 9928242

5-HT1B receptor modulation of prepulse inhibition: recent findings in wild-type and 5-HT1B knockout mice.

S C Dulawa1, R Hen, K Scearce-Levie, M A Geyer.   

Abstract

Sensorimotor gating of the startle reflex occurs when the presentation of a weak "prepulse" 30-500 msec prior to a startling stimulus inhibits the reflex, and is called prepulse inhibition (PPI). The study of PPI has recently been extended to mice to take advantage of recent advances in molecular genetics, because several neuropsychiatric disorders including schizophrenia, obsessive compulsive disorder, and schizotypal personality disorder are characterized by PPI deficits. Studies in wild-type and 5-HT1B knockout mice suggest that activation of 5-HT1B receptors decreases PPI. The direct 5-HT1A/1B agonist RU24969 decreases PPI in wild-type but not 5-HT1B knockout mice. Likewise, the serotonin releasing compounds MDMA(+), MBDB(+/-), and alpha-ethyltryptamine (AET) have no effect on PPI in wild-type mice, but increase PPI in 5-HT1B knockout mice. As the direct 5-HT1A agonist 8-OH-DPAT increases PPI in mice, the unmasking of these effects may also contribute to the PPI-increasing effects of 5-HT releasers in 5-HT1B knockout mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9928242     DOI: 10.1111/j.1749-6632.1998.tb10176.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding.

Authors:  Christopher Pittenger; Thomas G Adams; Jean-Dominique Gallezot; Michael J Crowley; Nabeel Nabulsi; Hong Gao; Stephen A Kichuk; Ryan Simpson; Eileen Billingslea; Jonas Hannestad; Michael Bloch; Linda Mayes; Zubin Bhagwagar; Richard E Carson
Journal:  J Affect Disord       Date:  2016-02-09       Impact factor: 4.839

2.  Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia.

Authors:  Taro Kishi; Masatsugu Moriwaki; Tsuyoshi Kitajima; Kunihiro Kawashima; Tomo Okochi; Yasuhisa Fukuo; Osamu Furukawa; Hiroshi Naitoh; Kiyoshi Fujita; Nakao Iwata
Journal:  Psychopharmacology (Berl)       Date:  2010-02-23       Impact factor: 4.530

Review 3.  Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Neuropharmacology       Date:  2011-01-20       Impact factor: 5.250

4.  Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice.

Authors:  Nancy A Shanahan; Kerri A Holick Pierz; Virginia L Masten; Christian Waeber; Mark Ansorge; Jay A Gingrich; Mark A Geyer; Rene Hen; Stephanie C Dulawa
Journal:  Biol Psychiatry       Date:  2008-11-14       Impact factor: 13.382

Review 5.  HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory.

Authors:  Antonio Drago; Silvia Alboni; Nicoletta Brunello; Brunello Nicoletta; Diana De Ronchi; Alessandro Serretti
Journal:  Eur J Clin Pharmacol       Date:  2009-10-07       Impact factor: 2.953

6.  Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha.

Authors:  Thomas J Gould; Scott P Bizily; Jan Tokarczyk; Michele P Kelly; Steven J Siegel; Stephen J Kanes; Ted Abel
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

7.  Serotonin 5-HT1B receptor-mediated behavior and binding in mice with the overactive and dysregulated serotonin transporter Ala56 variant.

Authors:  Kally C O'Reilly; Michelle Connor; Jamie Pierson; Lauren C Shuffrey; Randy D Blakely; Susanne E Ahmari; Jeremy Veenstra-VanderWeele
Journal:  Psychopharmacology (Berl)       Date:  2021-01-29       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.